机构：中金公司 研究员：毛晴晴/姚泽宇 1H25 新业务价值符合我们预期 友邦披露2025 半年报，新业务价值（VONB）在固定汇率（CER）和实际汇率（AER）下分别同比 +14%和+16%，基本符合我们和市场预期；每股营运利润（OPAT）同比+12%（AER 和CER），每股产 生的基本自由盈余同比上升10%（CER）和11%（AER），中期每股分红同比+10%至0.49港元，好于我 们和市场预期。 发展趋势 其他市场表现整体符合预期。1H25 友邦泰国VONB 同比+35%，受益于3月监管规则变化带来的一次性 购买，2Q25 保费增长相较1Q 已经有所放缓；友邦新加坡VONB 同比+16%，同样受益于2Q 产品迭代引 发的提前购买；友邦马来西亚代理人渠道VONB 较为疲软但已有复苏迹象，银保渠道的增长一定程度 抵消了上述负面影响；其他市场VONB 延续上升趋势。 关注独立主席换届后的战略方向。此前友邦公告Mark Tucker 将于2025 年10 月回归友邦担任独立非执行 主席及独立非执行董事，其曾在2010-2017年任友邦首席执行官兼总裁并取得优秀的经营业绩、受到较 多长线投资人认可，建议关注其上 ...

Core Insights - The performance of ten bank-affiliated insurance companies in the first half of 2025 shows a significant increase in premium income and net profit, indicating a strong growth trend in the sector [1][3]. Premium Income - The ten bank-affiliated insurance companies collectively achieved premium income of 3200.17 billion yuan, representing a year-on-year growth of 12.38%, outperforming the overall life insurance industry's growth rate of 6.6% [1][3]. - Among these companies, China Post Life Insurance led with premium income of 1180.72 billion yuan, a growth of 12.07% year-on-year [5]. - Other notable performers include: - CCB Life Insurance with 338.03 billion yuan, a growth of 22.88% - Agricultural Bank Life Insurance with 326.11 billion yuan, a growth of 24.20% - China Netherlands Life Insurance with 127.17 billion yuan, a growth of 36.48%, the highest among the group [4][5]. Net Profit - The total net profit for the ten companies reached 96.21 billion yuan, nearly doubling from 50.5 billion yuan in the same period last year, reflecting a growth of 90.51% [8]. - However, seven of the ten companies reported a decline in net profit compared to the previous year [8][11]. - Key net profit figures include: - China Post Life Insurance: 51.77 billion yuan, down 9.02% - Agricultural Bank Life Insurance: 7.43 billion yuan, down 33.72% - CCB Life Insurance: 5.65 billion yuan, down 5.68% - China Netherlands Life Insurance: 2.77 billion yuan, up 1631.25% [9][11]. Market Dynamics - The "bank-insurance integration" policy is expected to enhance the competitive advantage of bank-affiliated insurance companies by optimizing costs and focusing on product innovation and service upgrades [1][5]. - The average commission in the industry is projected to decrease by 30%, further influencing the market dynamics [5][6]. - The shift to new accounting standards has led to a divergence between profit growth and net asset reduction, with companies like China Netherlands Life Insurance and China CITIC Life Insurance experiencing significant net asset declines despite profit increases [12][13].

Investment Rating - The investment rating for AIA Group Limited is "Buy" (maintained) [1] Core Views - The report highlights that both New Business Value (NBV) and NBV Margin have increased, with a mid-year dividend per share rising by 10% year-on-year [1] - The company reported a mid-year NBV of $2.84 billion, a year-on-year increase of 14%, with a quarterly growth of 18.9% in Q2 [1] - The annualized new premium reached $4.94 billion, reflecting an 8% year-on-year growth [1] - The after-tax operating profit was $3.6 billion, up 6% year-on-year, aligning with the company's three-year target guidance [1] - The net profit was reported at $2.53 billion, a decrease of 24% year-on-year [1] - The embedded value stood at $70.9 billion, remaining stable since the beginning of the year, with an operating profit of $5.9 billion, up 9% year-on-year [1] - The report anticipates continued strong growth in Hong Kong and the mainland China markets, supported by the establishment of new branches [1] Summary by Sections Financial Performance - Insurance revenue is projected to grow from $17.514 billion in 2023 to $21.897 billion by 2027, with a compound annual growth rate (CAGR) of approximately 4.43% [1] - After-tax operating profit is expected to increase from $6.213 billion in 2023 to $8.307 billion by 2027, with a CAGR of about 8.37% [1] - Earnings per share (EPS) is forecasted to rise from $0.36 in 2023 to $0.93 by 2027 [1] - The embedded value (EV) per share is projected to grow from $6.42 in 2023 to $7.88 by 2027 [1] - The price-to-embedded value (P/EV) ratio is expected to decrease from 1.49 in 2023 to 1.21 by 2027 [1] Business Segments - The report indicates that Hong Kong remains the largest contributor to the group's NBV, accounting for 35% of the total, with a year-on-year increase of 24% [1] - The mainland China market showed a 10% year-on-year increase in NBV, with a quarterly growth of 15% in Q2 [1] - Thailand's NBV increased by 35% to $520 million, while Singapore's NBV rose by 16% to $260 million [1] - The overall NBV Margin improved by 3.8 percentage points to 57.7% [1] Investment Strategy - The company has reduced its allocation to fixed income while maintaining a stable proportion of equity assets [1] - The annualized net investment return rate was reported at 1.9%, a decrease of 0.1 percentage points year-on-year [1] - The report maintains previous profit forecasts, projecting embedded values of $73 billion, $77.6 billion, and $82.8 billion for 2025, 2026, and 2027, respectively [1]

Core Viewpoint - The practice of monthly premium disclosure by listed insurance companies in China has been broken, with major companies like China Life, China Ping An, and China Pacific Insurance no longer releasing this data [1][2]. Group 1: Reasons for Stopping Monthly Premium Disclosure - Regulatory bodies do not mandate insurance companies to disclose monthly premium income, allowing companies to have discretion over such disclosures [1][2]. - The implementation of new accounting standards (IFRS 17) has changed the way premium income is recognized, making previous data incomparable [1][2]. - Monthly premium income can fluctuate significantly due to various factors such as seasonality, marketing activities, and new product launches, which may not accurately reflect the long-term operational performance of insurance companies [2][3]. Group 2: Alternative Metrics for Evaluating Insurance Companies - Consumers should focus on the solvency adequacy of insurance companies, which indicates their ability to meet payout obligations under extreme risk scenarios [3][4]. - Investors should pay attention to indicators such as new business value, channel efficiency, comprehensive cost ratio, and investment return rate, which can be found in annual and semi-annual reports [3][4]. - Monitoring regulatory penalties against insurance companies can provide insights into their business quality and compliance levels [3][4].

Core Viewpoint - The practice of monthly premium disclosure by listed insurance companies in China has been broken, with major companies like China Life, China Ping An, and China Pacific Insurance no longer publishing this data [1][2]. Group 1: Reasons for Stopping Monthly Premium Disclosure - Regulatory bodies do not mandate insurance companies to disclose monthly premium income, allowing companies to have discretion over such disclosures [1][2]. - The implementation of new accounting standards (IFRS 17) has changed the way premium income is recognized, making previous data incomparable [1][2]. - Monthly premium income can fluctuate significantly due to various factors, such as seasonal trends and marketing activities, which may not accurately reflect the long-term operational stability of insurance companies [2][3]. Group 2: Alternative Metrics for Evaluating Insurance Companies - Consumers should focus on the solvency adequacy of insurance companies, which indicates their ability to meet obligations under extreme risk scenarios [3][4]. - Investors should pay attention to indicators such as new business value, channel efficiency, comprehensive cost ratio, and investment return rate, which are available in annual and semi-annual reports [3][4]. - Monitoring regulatory penalties against insurance companies can provide insights into their business quality and compliance levels [3][4].

Summary of Key Points from Conference Call Records Industry Overview - The insurance industry, particularly life insurance, is characterized as a long-term risk management tool significantly influenced by interest rate risks, contrasting with the short-term risk management of property insurance [1][6][17] - The Chinese critical illness insurance market experienced rapid growth due to inadequate healthcare systems and public health risk concerns, but the emergence of inclusive commercial insurance has led to a decline in market share [1][13] Core Insights and Arguments - Chinese insurance companies are currently facing pressure from interest rate spreads due to a shift in product structure from critical illness insurance to savings-type policies, resulting in increased liability costs and exacerbated issues from declining market interest rates [1][14][15] - To counteract the pressure from interest rate spreads, Chinese insurance companies are compelled to increase their allocation to equity assets to enhance investment returns, which can stabilize operations in a low valuation environment [1][15][17] - The design of life insurance products follows a cost-plus logic, where companies use actuarial techniques to assess mortality rates, expense ratios, and interest rates, incorporating a profit margin into the cost structure [1][7] Market Dynamics - In China, the number of agents is positively correlated with premium growth, especially during the rapid growth of critical illness insurance, indicating a heavy reliance on agents for selling protection products [1][9] - From a fundamental and valuation recovery perspective, Hong Kong stocks are preferred over A-shares, and insurance stocks are favored over brokerage firms due to significant valuation discounts and recovery potential [1][16] Investment Opportunities - Investment opportunities in the non-bank financial sector for 2025 are primarily focused on undervalued debt-like financial stocks, particularly insurance stocks, with a shift in focus from liability growth to investment changes [2][18] - Recommendations for future investments in the Chinese insurance sector include focusing on valuation recovery opportunities in Hong Kong stocks and selecting A-share stocks based on their elasticity [18] Additional Important Insights - The U.S. life insurance industry historically evolved by selling the underlying value concepts rather than just the products, which played a crucial role in its development [4][8] - The rapid growth of China's critical illness insurance market before 2012 was driven by insufficient major illness coverage in the healthcare system and increased public concern over health risks, particularly during periods of severe environmental pollution [12] - The decline in the critical illness insurance market post-2020 is attributed to the introduction of inclusive commercial insurance products that effectively replaced traditional critical illness insurance [13] This summary encapsulates the essential insights and dynamics of the life insurance industry as discussed in the conference call records, highlighting the challenges, market trends, and investment opportunities.

小摩强调香港对友邦保险新业务价值(NBV)的贡献约为30%，又指近期香港引入三项监管收紧措施，包 括分红(par)保单的展示上限降低(GL16/28)、前期销售佣金减少(GL16)、与香港风险资本准则(HKRBC) 框架相关的分红业务管理(GL34)。小摩初步认为，离岸销售活动可能放缓，特别是经纪渠道。因此，竞 争减少将带来机会，包括降低收购成本及改善流失率体验展望。 小摩表示，截至2024年12月，友邦保险现有寿险保单，在未来10年未折现可分配收益增至466亿美元(年 增8.6%)。小摩预测此余额将增至487亿美元(按半年增4.5%)，为更高的盈利增长前景提供信心。预计净 自由盈余生成将达24亿美元(年增9%)，截至2025年6月预估自由盈余余额为108亿美元。小摩预计，友邦 保险2025、2026、2027财年新业务价值年增率分别为15%、22%、24%。 （原标题：小摩：升友邦保险(01299)目标价至105港元 维持"增持"评级） 智通财经APP获悉，摩根大通发布研报称，友邦保险(01299)今年迄今表现优于大盘，股价自2024年4月 低点46港元上涨27%(恒生指数：23%)，似乎已反映多项正面因素 ...

Core Viewpoint - UBS estimates that AIA Group (01299) will see a 10% year-on-year increase in operating profit per share for the first half of the year, with post-tax operating profit expected to grow by 5% [1]. Financial Performance - The mid-term dividend is projected to increase by 9% to HKD 0.48 per share, although UBS believes that there will be no updates to the share buyback plan for the time being [1]. - UBS forecasts that the new business value (VNB) for AIA in the first half will grow by 16% and 15% when calculated at actual exchange rates (AER) and constant exchange rates (CER) respectively [1]. - The growth rate for the second quarter is expected to accelerate to 21% and 18% for AER and CER respectively, compared to 13% in the first quarter [1]. Market Performance - The strong performance in the Hong Kong and China markets is a key driver of growth, with the VNB growth rate in Hong Kong expected to rise from 16% in the first quarter to 28% [1]. - Excluding the impact of economic expectations, the VNB in the Chinese market is anticipated to grow by 12% [1]. Leadership Changes - Du Jiaqi will assume the role of new chairman on October 1, and significant strategic adjustments for the company are expected to become clearer following his appointment [1]. - UBS maintains a target price of HKD 88 and a "Buy" rating for AIA [1].

瑞银预测按实际汇率(AER)及固定汇率(CER)计算，友邦上半年新业务价值(VNB)将同比增长16%及 15%，估计第二季增速加快至21%及18%，对比首季为13%，主要由于香港及中国市场业务表现强劲， 其中香港CER基准VNB增速预期由首季的16%提升至28%，撇除经济预期变动影响后，料中国市场VNB 将增长12%。 瑞银发布研报称，估计友邦保险(01299)上半年每股经营利润将同比增长10%，税后经营溢利料增长 5%，预计中期股息增长9%至每股0.48港元，但相信暂时不会更新股份回购计划。该行指，杜嘉祺将于 10月1日上任新主席，其就职后公司重大战略调整预期会明朗化，维持目标价88港元，评级"买入"。 ...

Core Viewpoint - UBS forecasts AIA's new business value (VNB) to grow by 16% and 15% year-on-year under actual exchange rates (AER) and constant exchange rates (CER) respectively for the first half of the year, with a projected acceleration in growth to 21% and 18% in the second quarter compared to 13% in the first quarter, driven by strong performance in Hong Kong and mainland China markets [1] Group 1 - UBS estimates AIA's operating profit per share to increase by 10% year-on-year for the first half of the year [1] - After-tax operating profit is expected to grow by 5% [1] - The interim dividend is projected to rise by 9% to HKD 0.48 per share, although no updates on share buyback plans are anticipated [1] Group 2 - The new chairman, Du Jiaqi, will assume office on October 1, and significant strategic adjustments are expected to be clarified after his appointment [1] - UBS maintains a target price of HKD 88 for AIA and rates the stock as "Buy" [1]